MEASLES AND RUBELLA VACCINE LIVE (MR) – SYSTEMIC IMMUNOLOGICAL VIRAL PROPHYLAXIS & STABILIZATION THERAPY

The Measles and Rubella (MR) Vaccine is a high-precision, pharmaceutical-grade vaccine (Live Attenuated Virus) engineered for the clinical prevention of rubeola (measles) and rubella (German measles). It works through a sophisticated molecular mechanism: as a systemic live-attenuated vaccine, it introduces weakened strains of the Edmonston-Zagreb measles virus and the Wistar RA 27/3 rubella virus to the immune system. This action effectively triggers the systemic production of neutralizing antibodies and long-term T-cell memory, providing a stable clinical tool for clearing the risk of pneumonia, encephalitis, and Congenital Rubella Syndrome (CRS) in the high-transmission Nigerian environment.

In Nigeria, the MR vaccine is a premier clinical choice for routine childhood immunization (starting at 9 months) and mass systemic protection campaigns. It is particularly valued for its "Herd-Immunity" profile; by clearing the localized circulation of these viruses, it provides systemic protection for vulnerable individuals who cannot be vaccinated. At Sanlive Pharmacy, we ensure our MR vaccine stock is stored in strictly climate-controlled cold-chain environments (2°C to 8°C) to maintain the molecular stability of the attenuated viruses. This is critical because live vaccines are extremely thermosensitive; exposure to the intense Nigerian sun or high-temperature storage in non-pharmacy environments can cause the viruses to die, significantly reducing the product's ability to provide systemic immunity and leaving children unprotected.

Important: This is a potent systemic immunological therapy.

• The "9-Month" Rule: You should be aware that the first systemic dose is typically administered at 9 months of age; earlier administration may fail to clear the systemic risk because maternal antibodies can localized neutralize the live vaccine in the Nigerian healthcare landscape.

• The "Cold-Chain" Rule: You must ensure the MR vaccine is transported from the pharmacy in a systemic "Cool-Bag" with ice packs; the live viral particles will denature within minutes in the Nigerian heat, making the injection fail to work.

• The "Pregnancy-Avoidance" Rule: You must strictly ensure that women of childbearing age do not receive the systemic vaccine if they are pregnant or planning to conceive within the next month; the rubella component can systemically cross the placenta and cause localized fetal harm.

Key Uses & Benefits

• Measles Prevention: Effectively clearing the systemic risk of high fever, rash, and fatal pneumonia.

• Rubella Stabilization: Reducing the systemic spread of "German Measles" in the community.

• Congenital Rubella Syndrome Shield: Providing a systemic solution to prevent birth defects in future pregnancies.

• Encephalitis Protection: Clearing the systemic risk of localized brain inflammation and permanent disability.

• Long-Term Immune Memory: Providing a clinical solution for decades of systemic protection.

• Outbreak Response Support: Providing a systemic shield during localized viral surges in Nigerian schools.

• Targeted Immunological Reset: Providing a clinical anchor for lifelong viral health.

Who Should Use This Product?

• Infants (9 months and older) requiring a proactive, systemic solution for Measles and Rubella.

• Non-immune adolescents and adults requiring systemic viral protection under professional supervision.

Not recommended for: Individuals with severe systemic immunodeficiency (like symptomatic HIV or those on chemotherapy). It is strictly contraindicated for pregnant women and those with severe localized allergies to Neomycin or gelatin. Consult our pharmacist if the patient has a localized active fever or has recently received a systemic blood transfusion. Consult your doctor immediately if the child experiences localized "severe respiratory distress" or systemic "seizures" after injection, as these require professional clinical investigation for systemic stability in the Nigerian healthcare landscape.

Suggested Clinical Usage

Administered via the Subcutaneous (SC) Route, typically into the localized upper arm.

• The "Administration" Tip: The lyophilized powder must be systemically reconstituted with the provided sterile diluent; the clinical professional should inject the localized dose immediately after mixing.

• The "Wait" Phase: You should notice the systemic development of protective antibodies within 10 to 14 days of the systemic injection; a second dose is often required at 15 months to ensure a stable clinical shield.

• Consistency is Vital: To effectively maintain your child's health, follow the Nigerian National Programme on Immunization (NPI) schedule; skipping systemic doses leaves localized gaps in viral protection.

• The "Storage" Tip: Keep the vial in the refrigerator (2°C to 8°C); protect the systemic powder from localized light, as UV exposure in the Nigerian climate can destroy the live-attenuated antigens.

Common Side Effects

• Localized Injection Site Redness: A common systemic reaction where the needle entered.

• Systemic Mild Fever: A temporary reaction occurring 5 to 12 days after the dose.

• Localized Faint Rash: A normal systemic immune response as the body processes the live virus.

• Rare but serious: Thrombocytopenia—discontinue use if you see localized unexplained bruising.

• Rare: Occasional localized joint pain (more common in systemic adult recipients).

Seek medical advice immediately if you experience persistent high fever, fainting, or signs of a severe allergic reaction.

Manufacturer

Serum Institute of India / Various – Ensuring the MR vaccine meets international gold standards for efficacy and molecular purity.

Why Buy from Sanlive Pharmacy?

• 100% Authentic: Guaranteed original MR vaccine stock with verified batch numbers and secure NAFDAC registration.

• Potency Protection: Our professional cold-chain storage ensures the live-attenuated viruses remain active despite the Nigerian heat.

• Professional Guidance: Access to licensed pharmacists for clinical counseling on Immunization Schedules and Pregnancy Safety.

• Reliable Delivery: Fast and secure shipping across Nigeria, ensuring your essential viral support arrives in perfect, factory-sealed condition.

FAQs

• Can my child get "Measles" from the vaccine?

  Systemically, no. While the child may develop a localized mild fever or a few spots, these are signs the systemic immune system is building a stable clinical defense. The weakened virus cannot cause the localized full-blown disease in a healthy child.

• What if we "Missed" the 9-month dose?

  Systemically, you can "catch up" at any time. Our pharmacist recommends getting the systemic shield as soon as possible to clear the risk of localized infection in the Nigerian climate.

• Does it protect against "Mumps" too?

  No. This specific systemic formulation clears the risk for Measles and Rubella only. If you require systemic protection against Mumps, consult our pharmacist about the localized availability of the MMR (Measles, Mumps, Rubella) vaccine.

Where can I purchase this in Nigeria?

You can find verified, correctly stored Measles and Rubella Vaccine Live at Sanlive Pharmacy & Stores with professional cold-chain handling for guaranteed product integrity and professional immunological health support.

Order Measles and Rubella Vaccine from Sanlive Pharmacy with fast delivery nationwide.